April 25, 2023 02:07 PM EDT
FDA+
Manufacturing

Sun Phar­ma tem­porar­i­ly halts ship­ments from man­u­fac­tur­ing plant af­ter FDA let­ter

Tyler Patchen

News Reporter

Sun Phar­ma is paus­ing pro­duc­tion at one of its plants in In­dia af­ter fac­ing scruti­ny by US reg­u­la­tors over nec­es­sary cor­rec­tive work.

In a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

No­vo turns to Septer­na for oral obe­si­ty med­i­cines in deal worth up to $2.2B

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

Ad­vo­ca­cy groups and ex­perts call for decade-long ban on germline edit­ing

SK, Car­lyle bol­ster blue­bird bio bid; Theri­ni Bio rais­es $39M

CRISPR patent spat re­vived by fed­er­al ap­peals court rul­ing

A service from the Financial Times